[go: up one dir, main page]

AU6390596A - C-cam expression constructs and their application in cancer therapy - Google Patents

C-cam expression constructs and their application in cancer therapy

Info

Publication number
AU6390596A
AU6390596A AU63905/96A AU6390596A AU6390596A AU 6390596 A AU6390596 A AU 6390596A AU 63905/96 A AU63905/96 A AU 63905/96A AU 6390596 A AU6390596 A AU 6390596A AU 6390596 A AU6390596 A AU 6390596A
Authority
AU
Australia
Prior art keywords
application
cancer therapy
expression constructs
cam expression
cam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63905/96A
Inventor
Jer-Tsong Hsieh
Sue-Hwa Lin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of AU6390596A publication Critical patent/AU6390596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU63905/96A 1995-06-23 1996-06-21 C-cam expression constructs and their application in cancer therapy Abandoned AU6390596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49462295A 1995-06-23 1995-06-23
US494622 1995-06-23
PCT/US1996/010696 WO1997000954A1 (en) 1995-06-23 1996-06-21 C-cam expression constructs and their application in cancer therapy

Publications (1)

Publication Number Publication Date
AU6390596A true AU6390596A (en) 1997-01-22

Family

ID=23965246

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63905/96A Abandoned AU6390596A (en) 1995-06-23 1996-06-21 C-cam expression constructs and their application in cancer therapy

Country Status (2)

Country Link
AU (1) AU6390596A (en)
WO (1) WO1997000954A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19852804C1 (en) * 1998-11-16 1999-12-23 Christoph Wagener Pharmaceutical composition for manipulating angiogenesis
EP1165144A2 (en) * 1999-03-15 2002-01-02 Introgen Therapeutics, Inc. Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
JP2003501362A (en) 1999-05-28 2003-01-14 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム C-CAM as an angiogenesis inhibitor
AU2006249199A1 (en) 2005-05-12 2006-11-23 Introgen Therapeutics, Inc. P53 vaccines for the treatment of cancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL179877B1 (en) * 1993-07-13 2000-11-30 Rhone Poulenc Rorer Sa Replication defective adenovirus, cell line for infection with defective adenovirus and pharmaceutical agent PL PL PL PL PL PL PL PL PL PL

Also Published As

Publication number Publication date
WO1997000954A1 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
AUPN698495A0 (en) Improved therapeutic formulation and method
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
HUP9901908A3 (en) P16 expression constructs and their application in cancer therapy
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU7127196A (en) Nanoparticles in photodynamic therapy
AU5652096A (en) Azacycloalcane derivatives, their preparation and their applications in therapy
AU5773696A (en) Improvements in and relating to fixing
AU7216996A (en) A paf-acetylhydrolase and use in therapy
AU6128896A (en) Isoindole derivatives, their preparation and their application in therapy
AU4860693A (en) Piperidine derivatives, their preparation and their application in therapy
AU7674896A (en) Adenovirus-antisense k-ras expression vectors and their application in cancer therapy
AU7245296A (en) Mhc-class ii restricted melanoma antigens and their use in therapeutic methods
AU1507992A (en) 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapy
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU6390596A (en) C-cam expression constructs and their application in cancer therapy
AU7139996A (en) Mercaptoamide derivatives and their therapeutic use
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
AU5697996A (en) Peptidyl compounds and their therapeutic use
AU1036097A (en) 5-Naphthalen-1-yl-1,3-dioxane derivatives, their preparation and their therapeutic application
AU5975094A (en) 1,2,4-triazinone derivatives and their use in therapy